Epac1-mediated Rap1 activation is not required for the production of nitric oxide in BV2, murine microglial cells

Cited 17 time in scopus
Metadata Downloads
Title
Epac1-mediated Rap1 activation is not required for the production of nitric oxide in BV2, murine microglial cells
Author(s)
Eun Yi Moon; Su Young Oh; G H Han; C S Lee; Song Kyu Park
Bibliographic Citation
Journal of Neuroscience Research, vol. 81, no. 1, pp. 38-44
Publication Year
2005
Abstract
This study demonstrates that cyclic AMP (cAMP) production is induced by lipopolysaccharide (LPS) stimulation and activates two different pathways in murine BV2 microglial cells. Two principal effector proteins for cAMP are protein kinase A (PKA) and cAMP-responsive guanine nucleotide exchange factor (Epac), a Rap GDP exchange factor. When cells were treated with various cAMP level modulators, nitric oxide (NO) production increased as the result of posttreatment with Type IV phosphodiesterase (PDE4) inhibitor, rolipram or dibutyryl-cAMP (dbcAMP), at 2 hr after LPS stimulation. Intracellular cAMP increased due to LPS stimulation and the cAMP modulators phosphorylate transcription factor CREB, which is enhanced in turn by posttreatment with dbcAMP. In contrast, the Epac-specific cAMP analog 8-(4-chloro-phenylthio)- 2′-O-methyladenosine-3′,5′-cyclic monophosphate (8CPT-2Me-cAMP) activates Rap1 in the BV2 cells, but does not induce PKA activation, as judged by CREB phosphorylation. NO production was enhanced by posttreatment with dbcAMP but not by treatment with 8CPT-2Me-cAMP. This suggests that LPS-stimulated NO production is mainly PKA-dependent and also that Epac1-mediated Rap1 activation is not required for the induction of NO production.
Keyword
BV2cAMPEpac1Lipopolysaccharide (LPS)Nitric oxide (NO)PKARAP1
ISSN
0360-4012
Publisher
Wiley
DOI
http://dx.doi.org/10.1002/jnr.20535
Type
Article
Appears in Collections:
1. Journal Articles > Journal Articles
Files in This Item:
  • There are no files associated with this item.


Items in OpenAccess@KRIBB are protected by copyright, with all rights reserved, unless otherwise indicated.